3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with Allodynia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, H; Kem, WR; Mao, J; Martyn, JAJ; Ren, Y; You, Z; Zhang, W; Zhou, Y | 1 |
1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and Allodynia
| Article | Year |
|---|---|
The nonopioid cholinergic agonist GTS-21 mitigates morphine-induced aggravation of burn injury pain together with inhibition of spinal microglia activation in young rats.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Burns; Cholinergic Agonists; Hyperalgesia; Microglia; Morphine; NF-kappa B; Pain; Rats; Rats, Sprague-Dawley; Spinal Cord; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2022 |